LakeShore Biopharma Co., Ltd Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-06-30
|
-0.58
|
-1.34
|
-0.76
|
-131.03%
|
|
2024-03-31
|
-0.08
|
-0.19
|
-0.11
|
-137.50%
|
|
2023-12-31
|
-0.08
|
-0.11
|
-0.03
|
-37.50%
|
|
2023-09-30
|
-0.10
|
-0.16
|
-0.06
|
-60.00%
|
|
2022-09-30
|
0.00
|
0.22
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
0.07
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
0.28
|
0.00
|
0.00%
|
|
2021-12-31
|
0.00
|
0.11
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-06-30
|
-1.34
|
|
2024-03-31
|
-0.17
|
|
2022-03-31
|
0.42
|